In a multicenter study led by the University Hospital and the University Geriatric Medicine FELIX PLATTER Basel, a research group with participation from University of Basel, Inselspital, Bern University...

As the COVID-19 vaccines reach more people across the country, some people have asked: Could we delay the second dose of the Pfizer and Moderna vaccines to allow more people to be vaccinated more quickly?...

According to the Pew Research Center, 1 in 10 American adults have landed a long-term relationship from an online dating app, such as Tinder, OKCupid and Match.com. But what compels people to “swipe...

A technique frequently portrayed in dramatic resuscitation scenes in television and film is among several alternative methods to CPR that have shown no benefit in saving lives in a review by University...

Researchers at the National Institutes of Health and their collaborators found that inhaling unfragmented hyaluronan improves lung function in patients suffering from severe exacerbation of chronic obstructive...

Sen. Portman volunteers for Johnson & Johnson coronavirus vaccine trial Sen. Rob Portman, R-Ohio, calls recent vaccine developments ‘really exciting news,’ says ‘we need everybody to be...

Early data suggests that Pfizer’s coronavirus vaccine is more than 90% effective in preventing an infection with the virus that causes COVID-19, the company announced on Monday (Nov. 9).  The vaccine,...

WEDNESDAY, Oct. 21, 2020 — A combination of two “targeted” therapies can beat back a rare form of blood cancer — without the toxic effects of chemotherapy, a new study has found. In...

More than 20 million people in the U.S. suffer neuropathic pain. At least 25% of those cases are classified as unexplained and considered cryptogenic sensory polyneuropathy (CSPN). There is no information...

A team of researchers from University Hospital Zurich and the University of Zurich, the Swiss Federal Institute of Technology and biotechnology company Philochem, has found fusing cytokines with antibodies...